Quick Answer
OCULAR THERAPEUTIX, INC reported Stockholders Equity of $654.31 million for fiscal year 2025.
OCULAR THERAPEUTIX, INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $654.31M | +107.5% |
| 2024 | $315.34M | +246.0% |
| 2023 | $91.13M | +157.6% |
| 2022 | $35.38M | -59.8% |
| 2021 | $88.00M | +15.6% |
| 2020 | $76.09M | +2196.3% |
| 2019 | -$3.63M | -110.1% |
| 2018 | $35.88M | +37.2% |
| 2017 | $26.15M | -49.7% |
| 2016 | $52.01M | -41.9% |
| 2015 | $89.59M | +52.6% |
| 2014 | $58.70M | +198.7% |
| 2013 | -$59.47M | -27.6% |
| 2012 | -$46.61M | -42.4% |
| 2011 | -$32.73M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $258.23M | -26.6% | -15.6% |
| June 30, 2025 | $305.92M | -19.0% | +15.0% |
| March 31, 2025 | $265.93M | -34.8% | -15.7% |
| December 31, 2024 | $315.34M | +246.0% | -10.4% |
| September 30, 2024 | $352.02M | +4382.6% | -6.8% |
| June 30, 2024 | $377.69M | +12135.0% | -7.4% |
| March 31, 2024 | $407.98M | +4101.2% | +347.7% |
| December 31, 2023 | $91.13M | +157.6% | +1060.5% |
- OCULAR THERAPEUTIX, INC showed an increase of +107.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, OCULAR THERAPEUTIX, INC’s stockholders equity has grown by 2099.2% (from -$32.73 million to $654.31 million).
- The most recent figure is from OCULAR THERAPEUTIX, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: